NCT00882947View on ClinicalTrials.gov

Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Primary Hypertension
Interventions
DRUG

Ventavis (Iloprost, BAYQ6256)

Iloprost solution for inhalation, BAYQ6256, Synthetic Prostacyclin analog

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00882947 - Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH) | Biotech Hunter | Biotech Hunter